That is why Unilife isn't in the market of producing drugs to go to clinical trails, it produces the devices. That is Sanofi, Hikma and Astra Zeneca's problem, and they know that NOT all of the drugs will pass clinical trails, that is why they have so many trails ongoing. Just saying.
That is why Unilife isn't in the market of producing drugs to go...
-
- There are more pages in this discussion • 92 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)